Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
mesalamine
mesalamine
| Drug Name | Form | Strength | Non-Formulary | Restricted | Renal Dosing | REMS | Therapeutic Interchange | Notes |
|---|---|---|---|---|---|---|---|---|
| Pentasa | CAPSULE, EXTENDED RELEASE, ORAL | 250 mg | ||||||
| Delzicol | DELAYED RELEASE CAPSULE, ORAL | 400 mg | ||||||
| Asacol | DELAYED RELEASE TABLET, ORAL | 400 mg | ||||||
| Asacol HD | DELAYED RELEASE TABLET, ORAL | 800 mg | ||||||
| Mesalamine | ENEMA, RECTAL | 4 g/60 mL | ||||||
| Canasa | SUPPOSITORY, RECTAL | 1000 mg |
Last updated: Aug. 22, 2022
- Do Not Crush: Extended-release (a) Capsule - Note: maintain pH at less than or equal to 6.0
- Do Not Crush: Slow-release (a) Tablet
- Do Not Crush: Delayed-release Tablet
mesalamine